These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36154843)

  • 21. In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances.
    Vandeputte MM; Cannaert A; Stove CP
    Arch Toxicol; 2020 Nov; 94(11):3819-3830. PubMed ID: 32734307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA; Navani DM; Yoburn BC
    Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G.
    Wang YJ; Huang P; Blendy JA; Liu-Chen LY
    Addict Biol; 2014 May; 19(3):354-61. PubMed ID: 22862850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
    Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
    Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DAMGO-induced μ opioid receptor internalization and recycling restore morphine sensitivity in tolerant rat.
    Ma X; Chen R; Huang M; Wang W; Luo L; Kim DK; Jiang W; Xu T
    Eur J Pharmacol; 2020 Jul; 878():173118. PubMed ID: 32320702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seizure activity involved in the up-regulation of BDNF mRNA expression by activation of central mu opioid receptors.
    Zhang HN; Ko MC
    Neuroscience; 2009 Jun; 161(1):301-10. PubMed ID: 19303919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine.
    Bailey CP; Couch D; Johnson E; Griffiths K; Kelly E; Henderson G
    J Neurosci; 2003 Nov; 23(33):10515-20. PubMed ID: 14627635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia.
    Ueda H; Inoue M; Matsumoto T
    J Neurosci; 2001 May; 21(9):2967-73. PubMed ID: 11312280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
    Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB
    Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
    Chakrabarti S; Law PY; Loh HH
    J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.
    Datta U; Kelley LK; Middleton JW; Gilpin NW
    Psychopharmacology (Berl); 2020 Dec; 237(12):3729-3739. PubMed ID: 32857187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.
    Chaipatikul V; Loh HH; Law PY
    J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
    Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
    Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells.
    Gray RE; Munks MW; Haynes RR; Olsen GD
    Brain Res Bull; 2001 Mar; 54(5):499-505. PubMed ID: 11397539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hybrid peptides endomorphin-2/DAMGO: design, synthesis and biological evaluation.
    Mollica A; Costante R; Stefanucci A; Pinnen F; Luisi G; Pieretti S; Borsodi A; Bojnik E; Benyhe S
    Eur J Med Chem; 2013 Oct; 68():167-77. PubMed ID: 23974016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors.
    Zádor F; Otvös F; Benyhe S; Zimmer A; Páldy E
    Neurochem Int; 2012 Aug; 61(3):378-88. PubMed ID: 22613132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.